Trends, Insights, and Strategic Implications The first quarter of 2025 marked a dynamic start to the year for the biopharma sector, continuing momentum from 2024’s wave of transformative transactions. Mergers and acquisitions (M&A), strategic licensing agreements, and novel collaborations were driven by three core themes: expansion in oncology, growing investment in immunology and neurology, and […]
Key Trends and Insights Global Out-Licensing and Partnerships In 2024, the biopharma sector saw a remarkable resurgence in activity, driven by global licensing and partnerships. The U.S. led the market with $7.0 billion across 373 deals, followed by the EMEA with $3.9 billion in 167 deals and the APAC region with $3.0 billion in 133 […]
Transforming Medicine Oligonucleotide-based therapeutics are rapidly emerging as a transformative class of drugs, capable of targeting previously untreatable diseases at their genetic roots. These molecules, encompassing antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), and mRNA-based therapies, work by modulating gene expression with unparalleled precision. The global antisense oligonucleotide (ASO) drug market has experienced significant growth, […]
Transforming Precision Medicine with Targeted Therapies Radiopharmaceuticals are transforming precision medicine by offering targeted diagnostic and therapeutic solutions. These innovative treatments focus radiation on diseased tissues, minimizing damage to healthy cells. With significant advancements in diagnostics, theranostics, and radionuclide therapies, radiopharmaceuticals are transforming oncology, cardiology, and neurology. Despite challenges like isotope supply constraints and infrastructure […]
Episode 1: The Science and Business Behind Healthcare In the first episode of our podcast, host Alan Vanderborght, CEO of KYBORA, welcomes guest John Gregg, Chairman and CEO at BalinBac Therapeutics, for an engaging conversation about his extensive experience in the industry. They discuss the evolution of Healthcare, groundbreaking scientific innovations and the trends shaping […]
The intersection of artificial intelligence (AI) and protein biology marks the dawn of a transformative era in therapeutic development. Historically, the complexity of protein folding and design posed significant challenges, constrained by the limits of empirical methodologies. Recent breakthroughs, led by innovations such as DeepMind’s AlphaFold, have redefined our understanding of protein structure prediction. This […]
This document offers an in-depth analysis of molecular drug targets in key therapeutic areas, including oncology, immunology, neuroscience, and rare diseases. It highlights emerging trends such as the rise of personalized medicine, RNA-based therapeutics, disease-modifying strategies, and innovative technologies like gene therapies and platform-based discovery approaches.By examining both established and investigational agents, the analysis reveals […]
Spotlight on CAR-T, TIL, and TCR Therapies Cellular immunotherapies, including CAR-T, TIL, and TCR therapies, have transformed modern medicine, offering personalized approaches to treat cancer and autoimmune diseases. CAR-T therapy has demonstrated exceptional efficacy in hematologic malignancies, though challenges such as side effects, manufacturing complexity, and limited solid tumor applicability persist. Emerging in vivo CAR-T […]
Precision Cancer Therapy Driving Investment and Innovation Antibody-drug conjugates (ADCs) are rapidly emerging as a transformative force in precision medicine, revolutionizing cancer treatment by combining the targeting precision of monoclonal antibodies with the potent cytotoxic effects of small-molecule drugs. With the ability to precisely target and eliminate cancer cells while sparing healthy tissue, ADCs are […]
KYBORA is hiring – The Investment Banking Analyst will work closely with the Managing Director to execute strategic transactions and provide actionable insights for KYBORA’s clients. This position demands a detail-oriented and proactive individual with strong financial modeling, analytical, and communication skills. The Analyst will play a critical role in supporting M&A, licensing, fundraising, and […]
